Home LiteratureArticle Details
PMID: 24031123 Published · ppublish English Journal Article

Increased B7-H1 and B7-H4 Expressions on Circulating Monocytes and Tumor-Associated Macrophages are Involved in Immune Evasion in Patients with Gastric Cancer.

Yonago acta medica ·Vol. 54 ·No. 1 ·2011-03-00 ·Pages 1-10

Matsunaga T, Saito H, Ikeguchi M

Abstract

Expression of the costimulatory molecule B7-H4, a member of the inhibitory B7 family, has been reported to be upregulated on tumor-associated macrophages, and this overexpression may be involved in immune evasion in cancer patients. The present study was designed to investigate B7-H4 expression on monocytes/macrophages and its relationship with immune evasion in gastric cancer patients. B7-H4 expression on circulating monocytes and tumor-associated macrophages was evaluated by multicolor flow cytometry. Carboxyfluorescein succinimidyl ester proliferation assays and quantitative interferon-gamma enzyme-linked immunosorbent assays were carried out to determine the inhibitory effect of B7-H4+ monocytes on CD4+ T cells. B7-H4 expression on circulating monocytes was upregulated and these B7-H4+ monocytes showed immunosuppressive properties. B7-H4 expression was closely related to the depth of invasion, as well as the presence of lymphatic and venous invasion. There were significant correlations between B7-H4 expression and B7-H1 or HLA-DR expression on monocytes/macrophages in gastric cancer patients. B7-H4 expression was remarkably upregulated in gastric cancer tissues compared with peripheral blood samples. Complete surgical removal of the tumor decreased B7-H4 expression on circulating monocytes from gastric cancer patients. Cocultures of gastric cancer cell lines and monocytes led to upregulation of B7-H4 expression on monocytes. Increased B7-H4 expression on circulating monocytes and tumor-associated macrophages may be one of the key mechanisms responsible for immune evasion by tumors in gastric cancer.

Keywords
B7-H1 B7-H4 gastric cancer macrophage monocyte
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Matsunaga Tomoyuki
Division of Surgical Oncology, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, Yonago 683-8504, Japan.
Saito Hiroaki
Ikeguchi Masahide
References (35)
35 references, click to expand
  1. Negative co-receptors on lymphocytes.
    Curr Opin Immunol. 2002 Jun;14(3):391-6 PMID: 11973140
  2. B7-H4 overexpression in ovarian tumors.
    Gynecol Oncol. 2006 Jan;100(1):44-52 PMID: 16256178
  3. B7-h4 is highly expressed in ductal and lobular breast cancer.
    Clin Cancer Res. 2005 Mar 1;11(5):1842-8 PMID: 15756008
  4. Costimulatory and coinhibitory receptors in anti-tumor immunity.
    Immunol Rev. 2009 May;229(1):126-44 PMID: 19426219
  5. Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma.
    Cancer Res. 2007 Sep 15;67(18):8900-5 PMID: 17875732
  6. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses.
    Annu Rev Immunol. 2002;20:29-53 PMID: 11861596
  7. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation.
    Exp Cell Res. 2005 May 15;306(1):128-41 PMID: 15878339
  8. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Gastroenterology. 2007 Jun;132(7):2328-39 PMID: 17570208
  9. Global cancer statistics, 2002.
    CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108 PMID: 15761078
  10. Regulatory T cells, tumour immunity and immunotherapy.
    Nat Rev Immunol. 2006 Apr;6(4):295-307 PMID: 16557261
  11. Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity.
    Nat Immunol. 2006 Jul;7(7):755-62 PMID: 16732291
  12. B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival.
    Proc Natl Acad Sci U S A. 2006 Jul 5;103(27):10391-10396 PMID: 16798883
  13. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.
    Gynecol Oncol. 2006 Nov;103(2):405-16 PMID: 16725184
  14. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma.
    J Exp Med. 2006 Apr 17;203(4):871-81 PMID: 16606666
  15. The right place at the right time: novel B7 family members regulate effector T cell responses.
    Curr Opin Immunol. 2002 Jun;14(3):384-90 PMID: 11973139
  16. Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation.
    J Immunol. 2002 May 1;168(9):4272-6 PMID: 11970966
  17. CD4+ CD25+ suppressor T cells: more questions than answers.
    Nat Rev Immunol. 2002 Jun;2(6):389-400 PMID: 12093005
  18. Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family.
    J Immunol. 2003 Nov 1;171(9):4650-4 PMID: 14568939
  19. Targeting tumor-associated macrophages as a novel strategy against breast cancer.
    J Clin Invest. 2006 Aug;116(8):2132-2141 PMID: 16862213
  20. B7-h4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer.
    Cancer Res. 2006 Feb 1;66(3):1570-5 PMID: 16452214
  21. HLA class-I-restricted and tumor-specific CTL in tumor-infiltrating lymphocytes of patients with gastric cancer.
    Int J Cancer. 1997 Mar 17;70(6):631-8 PMID: 9096641
  22. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity.
    Nat Rev Immunol. 2004 May;4(5):336-47 PMID: 15122199
  23. Immunosuppressive networks in the tumour environment and their therapeutic relevance.
    Nat Rev Cancer. 2005 Apr;5(4):263-74 PMID: 15776005
  24. Antigen-induced regulatory T cells in autoimmunity.
    Nat Rev Immunol. 2003 Mar;3(3):223-32 PMID: 12658270
  25. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.
    Nat Med. 2003 May;9(5):562-7 PMID: 12704383
  26. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.
    Nat Med. 2004 Sep;10(9):942-9 PMID: 15322536
  27. Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1.
    J Exp Med. 2009 Jun 8;206(6):1327-37 PMID: 19451266
  28. Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma.
    Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):721s-726s PMID: 17255300
  29. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.
    Nat Med. 2002 Aug;8(8):793-800 PMID: 12091876
  30. B7-H3 and B7-H4 expression in non-small-cell lung cancer.
    Lung Cancer. 2006 Aug;53(2):143-51 PMID: 16782226
  31. The expression of tumor-rejection antigen "MAGE" genes in human gastric carcinoma.
    Gastroenterology. 1995 Nov;109(5):1522-5 PMID: 7557134
  32. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance.
    Immunol Rev. 2001 Aug;182:18-32 PMID: 11722621
  33. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.
    Gastroenterology. 2008 Jul;135(1):234-43 PMID: 18485901
  34. Japanese Classification of Gastric Carcinoma - 2nd English Edition -
    Gastric Cancer. 1998 Dec;1(1):10-24 PMID: 11957040
  35. "Re-educating" tumor-associated macrophages by targeting NF-kappaB.
    J Exp Med. 2008 Jun 9;205(6):1261-8 PMID: 18490490
Article Info
Journal
Yonago acta medica
Abbr.
Yonago Acta Med
ISSN
0513-5710
Published
2011-03-00
Epub
2011-00-01
Pages
1-10
Language
English
Region
Japan
NLM ID
0414002
PMCID
PMC3763800
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com